Table 1.
Characterization of the Prepared Nanoparticles, Each Formula Containing 25 mg Drug
| Formula Code | Polymer Type | Polymer (mg) | Solvent Type | Size (nm)* | PDI* | EE%* | Zeta Potential* |
|---|---|---|---|---|---|---|---|
| F1 | PLGA 75:25 |
50 | Acetone | 323.5±25.17 | 0.20±0.01 | 74.30±2.40 | −30.20±4.51 |
| F2 | 100 | 290.36±15.34 | 0.27±0.07 | 89.36±3.37 | −24.73±0.20 | ||
| F3 | 50 | DCM | 252.26±2.81 | 0.08±0.04 | 66.10±5.73 | −16.76±0.11 | |
| F4 | 100 | 238.00±7.21 | 0.06±0.00 | 90.43±8.81 | −19.66±0.98 | ||
| F5 | PLGA 50:50 |
50 | Acetone | 401.55±25.95 | 0.40±0.02 | 76.70±6.45 | −23.23±1.04 |
| F6 | 100 | 352.75±43.06 | 0.48±0.02 | 84.75±7.19 | −15.30±0.34 | ||
| F7 | 50 | DCM | 294.00±5.65 | 0.09±0.03 | 71.30±1.69 | −12.15±0.21 | |
| F8 | 100 | 267.56±8.46 | 0.14±0.03 | 90.32±4.55 | −12.46±0.49 |
Note: *Data are expressed as mean ± SD (n=3).